SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

QNT is drawing attention for a sharp, volatile rally and repeated attempts to break through resistance, with traders debating whether pullbacks are buying opportunities or signs of further downside. Bulls point to limited supply and anticipated institutional use of Quants network, while skeptics question how much that adoption would translate into demand for the token.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAIs latest Ultrafast model runs on Nvidia GPUs have raised concerns about Cerebras key customer relationship, while staged IPO share unlocks and insider selling add pressure. Bulls cite Sam Altmans reassurance of a close partnership and Cerebras AI-inference opportunity, leaving traders divided over whether the selloff reflects lasting business risk or temporary uncertainty and share supply.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion centers on the Trump administrations Iran conflict, military escalation and elevated fuel costs, alongside criticism of the economy and speculation about the midterms. Sentiment toward DJT is largely bearish, with traders calling the stock overvalued or prone to pump-and-dump moves, though a few expect a rebound.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is under pressure after Kodiaks Zenkuda wet-AMD results raised competitive concerns; bears see a higher bar for AXPAXLI, while bulls argue the trials are not directly comparable and point to AXPAXLIs durability results and planned NDA filing as reasons for optimism.

Pump.fun

PUMP.fun is drawing attention amid volatile price moves and renewed rebound and breakout chatter; bullish traders cite the platforms revenue and token buybacks as supportive, while skeptics warn of selloffs and question the momentum.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A weaker-than-expected jobs report eased expectations for further Fed tightening and pulled Treasury yields lower, prompting a relief bounce in rate-sensitive small caps. Traders remain divided on whether IWMs rebound near its 200-day average marks a turn or is temporary, given its recent underperformance and continued exposure to elevated rates.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Traders are reacting to a favorable natural-gas storage report and expectations that hot weather will support power demand, fueling hopes for a rebound in gas futures. The discussion remains divided, with bulls citing tighter storage while skeptics point to seasonal demand weakness, strong production, and BOILs futures-roll and leverage-related decay risks.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The G7s coordinated release of emergency oil and diesel stocks, alongside Trump ruling out a U.S. diesel export ban, is weighing on USO as traders assess whether added supply can ease energy-market pressure. The community is split: bears view the release as a reason for further weakness, while oil bulls argue it is a temporary fix amid ongoing Iran-related disruption and tight refined-product supplies.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings steep slide to multi-year lows is fueling debate over whether Kalshi and Polymarket are taking share and whether investment in DKeX will weigh on margins amid legal and regulatory uncertainty. Bears see intensifying competition as a threat, while bulls point to rising DKeX volume and sportsbook activity as evidence the business can hold up.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs reported consideration of a Texas fab campus is drawing attention as a potential expansion of U.S. chip capacity amid demand from major AI customers. Traders are also highlighting bullish call activity and momentum toward recent highs, though some are questioning whether the rally will hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire CLEARWATER, Fla., May 27, 2026 CLEARWATER...

Apyx Medical (APYX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of +54.55% and +6.23%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Perrigo (PRGO) Q1 Earnings Beat Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of +10.26% and -4.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC

AIGH Capital Management LLC bought a new position in shares of Apyx Medical Corporation (NASDAQ:APYX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,104,970 shares of the company's stock, valued at approximately $3,867,000. A...

Apyx Medical (APYX) Expected to Announce Earnings on Thursday

Apyx Medical (NASDAQ:APYX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-apyx-medical-co-stock...

Apyx Medical Corporation (NASDAQ:APYX) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold...

Apyx Medical (NASDAQ:APYX) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen lowered shares of Apyx Medical from a "buy" rating to a "hold" rating in a research note on Sunday...

Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?

Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Apyx Medical Corp

Bearish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

APYX Apyx Medical Corp